Provided by Tiger Trade Technology Pte. Ltd.

Albireo Pharma, Inc.

44.15
0.0000
Volume:- -
Turnover:- -
Market Cap:913.96M
PE:-6.56
High:44.15
Open:44.15
Low:44.15
Close:44.15
52wk High:44.15
52wk Low:44.15
Shares:20.70M
Float Shares:17.14M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.7337
EPS(LYR):-1.7705
ROE:-93.08%
ROA:-24.94%
PB:9.13
PE(LYR):-24.94

Loading ...

Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2020

Major Issues Report

8-K - Current report
Jun 15, 2020

Major Issues Report

8-K - Current report
Jun 09, 2020

Major Issues Report

8-K - Current report
May 14, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 07, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 26, 2020

Major Issues Report

8-K - Current report
Mar 02, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2020

Major Issues Report

8-K - Current report
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Jan 30, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Jan 29, 2020

Major Issues Report

Current report, items 2.02, 8.01, and 9.01